SNAP benefits are back online, but while those benefits were on pause, people and private companies like our parent company, ...
DexCom, a leading manufacturer of continuous glucose monitoring systems, is confronting one of the most significant ...
Cloud firm Datadog was added to the S&P 500, instead of the larger Robinhood. The Navy’s F/A-XX advanced, sixth-generation fighter jet might not happen, according to a report, hammering shares of the ...
LB Pharmaceuticals and Celldex have separately stepped up their respective launch preparations by appointing new chief commercial officers, according to a pair of announcements this week. | LB ...
NEW YORK, NY - November 6, 2025 ( NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM) on ...
Zacks Investment Research on MSN
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now
DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by a huge potential in the CGM market. A strong ...
Celldex (NASDAQ: CLDX) today announced the appointment of Teri Lawver as Senior Vice President, Chief Commercial Officer. Ms.
Medical device maker Insulet on Thursday posted third-quarter results that surpassed Wall Street's expectations on strong demand for its wearable insulin pumps, which eliminate the need for daily ...
Medical device company DexCom (NASDAQ:DXCM) will be reporting results this Thursday after market close. Here’s what you need to know. DexCom beat analysts’ revenue expectations by 2.8% last quarter, ...
Celldex Therapeutics, Inc.: Celldex Announces Appointment of Teri Lawver as Chief Commercial Officer
Celldex (NASDAQ: CLDX) today announced the appointment of Teri Lawver as Senior Vice President, Chief Commercial Officer. Ms. Lawver is an accomplished ...
Numerous comments on a Facebook group called “Dexcom G7 – Issues and Complaints” has brought to light a problem that users are referring to as “goose necking.” MD+DI learned more about this issue – ...
Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device. Benzinga reached out to DexCom for comments and is yet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results